Biochemistry · Cancer Biochemistry and Tumor Markers (Oncogenes, Warburg, Oncometabolites, Apoptosis)

A 55-year-old man undergoes molecular profiling of a pancreatic adenocarcinoma. Sequencing reveals a point mutation in a proto-oncogene that encodes a small monomeric GTP-binding protein. The mutant protein retains GTP binding but has markedly reduced intrinsic GTPase activity. Which protein is mutated?

  • A JAK2
  • B RAS
  • C SRC
  • D MYC
Correct answer: B. RAS

Explanation

RAS is a small monomeric GTP-binding signal transducer that is active in the GTP-bound state. Mutant RAS loses GTPase activity and cannot be switched off by GAPs, so it signals growth continuously. JAK2 is a tyrosine kinase linked to cytokine receptors, SRC is a non-receptor tyrosine kinase, and MYC is a nuclear transcription factor, none of which bind GTP.

Reference: Robbins and Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Cancer Biochemistry and Tumor Markers (Oncogenes, Warburg, Oncometabolites, Apoptosis) MCQs

See all Cancer Biochemistry and Tumor Markers (Oncogenes, Warburg, Oncometabolites, Apoptosis) MCQs →